Sort by
Refine Your Search
-
of the ICCVS is the development of personalized vaccine against non-small cell lung cancer (NSCLC). The approach is based on the use of cancer specific T cells that are selected by the special algorithm
-
elaborated an algorithm for identification of cancer specific T cells, which selectively kill autologous tumour but not healthy lung tissue. Simultaneously, we have developed the method for identification and
-
elaborated an algorithm for identification of cancer specific T cells, which selectively kill autologous tumour but not healthy lung tissue. Simultaneously, we have developed the method for identification and
Searches related to algorithm
Enter an email to receive alerts for algorithm positions